Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.

CONCLUSION: Frontline IVC (plus additional IAC and/or plaque radiotherapy) for retinoblastoma provided complete tumour control for groups A (96%), B (91%), C (91%), D (71%) and E (32%), avoiding enucleation or EBRT and was lasting for up to 20 years.
PMID: 32051141 [PubMed - as supplied by publisher]

Source: The British Journal of Ophthalmology - February 11, 2020 Category: Opthalmology Authors: Shields CL, Bas Z, Tadepalli S, Dalvin LA, Rao R, Schwendeman R, Lally SE, Shields JA, Shah A, Leahey A Tags: Br J Ophthalmol Source Type: research